FIELD: chemistry.
SUBSTANCE: invention relates to biotechnology, specifically to obtaining modified IGF-1 proteins and can be used in medicine. Constructed is a polypeptide which contains a human IGF-1 precursor protein, wherein amino acids G1, P2 and E3 are removed as a result of deletion or amino acid E3 is removed as a result of deletion, and wherein amino acid R37 is replaced with alanine and amino acids R71 and R72 are removed as a result of deletion. The cleavage of the E-peptide from IGF-1 by a protease is reduced as a result of said modifications. The obtained polypeptide is used to treat a musculoskeletal disease, diabetes, conditions associated with neuron death, anaemia, chronic obstructive pulmonary disease and burn injury.
EFFECT: invention enables to obtain stabilised polypeptides containing a modified sequence of an IGF-1 precursor, in which the cleavage of the E-peptide from IGF1 which occurs in natural physiological conditions is reduced.
21 cl, 12 dwg, 1 tbl, 82 ex
Title | Year | Author | Number |
---|---|---|---|
TARGETED THERAPEUTIC LYSOSOMAL ENZYME FUSION PROTEINS AND USES THEREOF | 2013 |
|
RU2680581C2 |
PRODUCTION OF POLYPEPTIDE CONJUGATED WITH POLY(ETHYLENEGLYCOL) FRAGMENT, NUCLEIC ACID AND FUSED POLYPEPTIDE MEANT FOR APPLICATION WITH THIS PROCESS | 2011 |
|
RU2584572C2 |
ANTI-IGF-1R ANTIBODY AND USE THEREOF AS AN ADDRESS VECTOR FOR CANCER TREATMENT | 2015 |
|
RU2698977C2 |
COMBINED APPLICATION OF TRAPS OF GDF AND ERYTHROPOIETIN RECEPTOR ACTIVATORS FOR INCREASING ERYTHROCYTE CONTENT | 2010 |
|
RU2592670C2 |
COMBINED USE OF GDF TRAPS AND ACTIVATORS OF ERYTHROPOIETIN RECEPTORS TO INCREASE ERYTHROCYTE CONTENT | 2017 |
|
RU2732229C2 |
COMBINED ADMINISTRATION OF GDF TRAPS AND ERYTHROPOETIN RECEPTOR ACTIVATORS FOR INCREASING CONTENT OF ERYTHROCYTES | 2010 |
|
RU2642302C1 |
NUCLEOTIDE AND AMINO ACID SEQUENCES OF OVICELL FACTORS FOR OVARY FOLLICLE GROWTH CHANGE IN VIVO OR IN VITRO | 2001 |
|
RU2270862C2 |
ACTIVIN-ACTRII ANTAGONISTS AND USES THEREOF FOR TREATING BONE AND OTHER DISORDERS | 2013 |
|
RU2678117C2 |
BINDING PROTEINS SPECIFIC TO INSULIN-LIKE GROWTH FACTORS, AND USING THEM | 2013 |
|
RU2549703C2 |
ANTIBODY AGAINST IGF-I RECEPTOR | 2018 |
|
RU2785305C2 |
Authors
Dates
2013-03-10—Published
2007-06-06—Filed